Latest News and Press Releases
Want to stay updated on the latest news?
-
PRESS RELEASE Ergomed strongly positioned for future growth in new partnership with Permira Permira completes acquisition of Ergomed for £703.1 millionThrough this partnership, Permira will support...
-
RNS PRESS RELEASE Ergomed expands operations in Japan New legal entity and regional office established in Tokyo responding to client demand Guildford, UK – 26 April 2021: Ergomed plc (LSE: ERGO)...
-
PRESS RELEASE Ergomed expands operations in Japan New legal entity and regional office established in Tokyo responding to client demand Guildford, UK – 26 April 2021: Ergomed plc (LSE: ERGO)...
-
PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the strategically important US market MedSource’s...
-
PRESS RELEASE Interim results for the six months ended 30 June 2020 Services strategy drives revenue and profit growthOrder book growth underpins high forward visibility Total revenue growth of...
-
PRESS RELEASE Ergomed H1 2020 Trading Update EBITDA for FY 2020 expected to be materially ahead of market expectationsIntegrated pharmaceutical services business demonstrates resilience during...
-
PRESS RELEASE Annual General Meeting Statement Guildford, UK – 10 June 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing specialised services to the...
-
PRESS RELEASE Ergomed to Present at Jefferies Virtual 2020 Healthcare Conference Guildford, UK – 28 May 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the 'Company'), a company focused on providing...
-
RNS REACHPRESS RELEASE Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation PrimeVigilance collaboration with Automation Anywhere and DataRobot to...
-
PRESS RELEASE Ergomed Announces Provision of Clinical Research Services for Second COVID-19 Clinical Development Programme Guildford, UK – 6 April 2020: Ergomed plc (LSE: ERGO) ('Ergomed' or the...